61 phd-agent-based-modelling Postdoctoral positions at University of Washington in United States
Sort by
Refine Your Search
-
models to simulate lifeless and inhabited worlds, and Developing disequilibrium-, redox-, and information-based metrics to understand and quantify the influence of life on planetary environments
-
optimization and ODE-based modeling Strong communication skills to interface with experts within the ATN, document the software and publish the results in the peer-reviewed literature Instructions Applicants
-
genetic mutations. We aim to advance our understanding of these diseases and to develop and translate therapeutic strategies for future clinical practice. The applicant is expected to work on mouse models
-
scientific papers, and contribute to the overall preparation of research for publication. To assist in the training of PhD and undergraduate students. Working Conditions: This position works in a laboratory
-
experience in molecular and cellular neurobiology to study neuronal regeneration and preservation in retinal mouse models of injury and disease. This project will examine how cellular metabolism impacts
-
protective equipment and to provide standard care to research animals. Salary Range: Base pay is commensurate with experience. Applicant Special Instructions: To apply, please submit the following documents
-
Position Summary Dr. Amargant-Riera’s research laboratory focuses on understanding the mechanisms that define oocyte quality. The lab uses mouse models and human samples to investigate
-
, to define novel biomarkers, and to identify novel therapeutical targets. We have pioneered in the integration of genetics with omic data to identify proteomic signatures and develop novel predictive models
-
eating disorders. Additional responsibilities include contributing to other ongoing clinical research on evidence-based digital treatments for eating disorders, providing mentorship to junior team members
-
, tumor immunology organotypic in-vitro models, genetically engineered animal models and human tissues from clinical trials. All these approaches are brought to bear on impactful questions in tumor